Based on ratings from 15 stock analysts, the Waters Corp stock price is expected to decrease by 0.61% in 12 months. This is calculated by using the average 12-month stock price forecast for Waters Corp. The lowest target is $325 and the highest is $415. Please note analyst price targets are not guaranteed and could be missed completely.
WAT is a stock in Healthcare which has been forecasted to be worth $378.4 as an average. On the higher end, the forecast price is $415 USD by Tycho Peterson from Jefferies and on the lower end WAT is forecasted to be $325 by Luke Sergott from Barclays.
These are the latest 20 analyst ratings of WAT.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Luke Sergott Barclays | Underweight | $360 | Maintains | Nov 4, 2024 |
Eve Burstein Bernstein | Market Perform | $360 | Maintains | Nov 4, 2024 |
Justin Bowers Deutsche Bank | Hold | $325 | Maintains | Nov 4, 2024 |
Brandon Couillard Wells Fargo | Overweight | $415 | Maintains | Nov 4, 2024 |
Daniel Arias Stifel | Hold | $360 | Maintains | Nov 4, 2024 |
Rachel Vatnsdal JP Morgan | Neutral | $380 | Maintains | Nov 4, 2024 |
Dan Brennan TD Cowen | Hold | $410 | Maintains | Nov 4, 2024 |
Luke Sergott Barclays | Underweight | $330 | Maintains | Oct 15, 2024 |
Tycho Peterson Jefferies | Buy | $415 | Upgrade | Oct 8, 2024 |
Vijay Kumar Evercore ISI Group | In-Line | $355 | Maintains | Oct 1, 2024 |
Brandon Couillard Wells Fargo | Overweight | $360 | Initiates | Aug 27, 2024 |
Luke Sergott Barclays | Underweight | $300 | Maintains | Aug 1, 2024 |
Puneet Souda Leerink Partners | Outperform | $375 | Upgrade | Aug 1, 2024 |
Justin Bowers Deutsche Bank | Hold | $310 | Maintains | Aug 1, 2024 |
Dan Brennan TD Cowen | Hold | $363 | Maintains | Aug 1, 2024 |
Vijay Kumar Evercore ISI Group | In-Line | $300 | Maintains | Jul 2, 2024 |
Luke Sergott Barclays | Underweight | $275 | Maintains | Jun 28, 2024 |
Catherine Ramsey Baird | Neutral | $312 | Maintains | May 8, 2024 |
Dan Brennan TD Cowen | Hold | $358 | Maintains | May 8, 2024 |
Luke Sergott Barclays | Underweight | $295 | Maintains | May 8, 2024 |
When did it IPO
1995
Staff Count
7,900
Country
United States
Sector/Industry
Healthcare/Diagnostics & Research
CEO
Dr. Udit Batra Ph.D.
Market Cap
$22.91B
In 2023, WAT generated $2.96B in revenue, which was a decrease of -0.52% from the previous year. This can be seen as a signal that WAT's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Waters has expanded its manufacturing footprint by opening a 45,000 sq ft facility at Longbridge Business Park, enhancing precision machining and metrology capacity for future growth.
Why It Matters - Waters expanding its manufacturing capacity signals strong growth potential, enhancing competitiveness and addressing future demand, which can positively influence stock performance and investor confidence.
Summary - Waters_connectโข Data Intelligence software enhances laboratory efficiency by offering real-time analytics and audit readiness, improving risk visibility and reducing audit preparation time.
Why It Matters - The waters_connectโข software enhances lab efficiency and compliance, reducing audit preparation time and risks of regulatory issues, which can lead to improved profitability and competitive advantage for companies.
Summary - WAT's Q3 2024 results indicate growth in pharma and industrial sectors, but sales in China have declined, presenting challenges for the company.
Why It Matters - WAT's growth in pharma and industrial sectors signals strong demand, while declining China sales could impact future revenue and market strategy, affecting overall investor sentiment.
Summary - Waters Corp raised its annual profit forecast after exceeding Q3 profit and revenue estimates, driven by increased demand for drug development and research products.
Why It Matters - Waters Corp's raised profit forecast signals strong demand in drug development, indicating robust growth potential, which can positively impact stock performance and investor sentiment.
Summary - Waters Corp. (WAT) shares rose nearly 20% after reporting third-quarter sales and earnings exceeding analysts' expectations, marking the highest daily performance in the S&P 500.
Why It Matters - Waters Corp.'s strong Q3 performance indicates robust demand and effective management, potentially enhancing investor confidence and driving stock prices higher.
Summary - Major U.S. equities indexes rebounded on Friday, driven by positive investor sentiment following strong earnings from Amazon (AMZN), after two prior negative trading sessions.
Why It Matters - Strong earnings from Amazon boost investor sentiment, indicating potential growth in e-commerce and cloud sectors, which can drive broader market recovery and influence investment strategies.